These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31511362)

  • 21. FYVE domain-containing protein ZFYVE28 regulates EGFR-signaling in podocytes but is not critical for the function of filtration barrier in mice.
    Zambrano S; Rodriguez PQ; Guo J; Möller-Hackbarth K; Schwarz A; Patrakka J
    Sci Rep; 2018 Mar; 8(1):4712. PubMed ID: 29549365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of a local tissue angiotensin system in podocytes by mechanical strain.
    Durvasula RV; Petermann AT; Hiromura K; Blonski M; Pippin J; Mundel P; Pichler R; Griffin S; Couser WG; Shankland SJ
    Kidney Int; 2004 Jan; 65(1):30-9. PubMed ID: 14675034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cabin1 localizes in glomerular podocyte and undergoes nuclear translocation during podocyte injury.
    Wen Y; Wang Z; Liu L; Zhang Y; Zhou P; Liang J
    Ren Fail; 2015; 37(8):1344-8. PubMed ID: 26275115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.
    Li SY; Chu PH; Huang PH; Hsieh TH; Susztak K; Tarng DC
    Sci Rep; 2019 Apr; 9(1):6693. PubMed ID: 31040292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A molecular mechanism for angiotensin II receptor blocker-mediated slit membrane protection: Angiotensin II increases nephrin endocytosis via AT1-receptor-dependent ERK 1/2 activation.
    Königshausen E; Zierhut UM; Ruetze M; Rump LC; Sellin L
    FASEB J; 2024 Sep; 38(17):e70018. PubMed ID: 39212304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.
    Hsu HH; Hoffmann S; Endlich N; Velic A; Schwab A; Weide T; Schlatter E; Pavenstädt H
    J Mol Med (Berl); 2008 Dec; 86(12):1379-94. PubMed ID: 18773185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
    Ren J; Lu X; Hall G; Privratsky JR; Robson MJ; Blakely RD; Crowley SD
    Am J Physiol Renal Physiol; 2022 Feb; 322(2):F164-F174. PubMed ID: 34894725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of nephrin phosphorylation inducted by dexamethasone and angiotensin II in podocytes.
    Yu M; Ren Q; Yu SY
    Mol Biol Rep; 2014 Jun; 41(6):3591-5. PubMed ID: 24515388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ste20-like kinase, SLK, a novel mediator of podocyte integrity.
    Cybulsky AV; Papillon J; Guillemette J; Belkina N; Patino-Lopez G; Torban E
    Am J Physiol Renal Physiol; 2018 Jul; 315(1):F186-F198. PubMed ID: 29187370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 33. Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy.
    Bensaada I; Robin B; Perez J; Salemkour Y; Chipont A; Camus M; Lemoine M; Guyonnet L; Lazareth H; Letavernier E; Hénique C; Tharaux PL; Lenoir O
    Kidney Int; 2021 Jul; 100(1):90-106. PubMed ID: 33675847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice.
    Ishizaka M; Gohda T; Takagi M; Omote K; Sonoda Y; Oliva Trejo JA; Asao R; Hidaka T; Asanuma K; Horikoshi S; Tomino Y
    Biochem Biophys Res Commun; 2015 Nov; 467(3):549-55. PubMed ID: 26435502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chloride intracellular channel 5A stimulates podocyte Rac1, protecting against hypertension-induced glomerular injury.
    Tavasoli M; Li L; Al-Momany A; Zhu LF; Adam BA; Wang Z; Ballermann BJ
    Kidney Int; 2016 Apr; 89(4):833-47. PubMed ID: 26924049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier.
    Boi R; Bergwall L; Ebefors K; Bergö MO; Nyström J; Buvall L
    J Am Soc Nephrol; 2023 Apr; 34(4):641-655. PubMed ID: 36735952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Rab-Rabphilin system in injured human podocytes stressed by glucose overload and angiotensin II.
    Martinez-Arroyo O; Ortega A; Perez-Hernandez J; Chaves FJ; Redon J; Cortes R
    Am J Physiol Renal Physiol; 2020 Aug; 319(2):F178-F191. PubMed ID: 32567349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
    J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Losartan reverses glomerular podocytes injury induced by AngII via stabilizing the expression of GLUT1.
    Yu SY; Qi R; Zhao H
    Mol Biol Rep; 2013 Nov; 40(11):6295-301. PubMed ID: 24062074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis.
    Hsu HH; Hoffmann S; Di Marco GS; Endlich N; Peter-Katalinić J; Weide T; Pavenstädt H
    Kidney Int; 2011 Nov; 80(9):959-969. PubMed ID: 21814176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.